本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Revolution Medicines, Inc.

38.02
-0.4800-1.25%
盘后38.020.00000.00%17:23 EDT
成交量:140.23万
成交额:5,338.02万
市值:70.82亿
市盈率:-9.46
高:38.47
开:38.26
低:37.85
收:38.50
数据加载中...
2024/10/25

重要事件披露

Form 8-K - Current report
2024/10/23

重要事件披露

Form 8-K - Current report
2024/10/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/07

重要事件披露

Form 8-K - Current report
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]